BioCatalystWatch
ACXPWorkspace / ACXP / OverviewCompany library
Acurx Pharmaceuticals, Inc. logo

Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc. (ACXP)

Website

Price
Market cap
Next catalyst2027ibezapolstat · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

ACX-375C

DNA polymerase IIIC (PolC)

PreINDP1P2P3FilingApproved
ibezapolstat

DNA polymerase IIIC (PolC)

PreINDP1P2P3FilingApproved
Upcoming / outlook

ibezapolstat

DNA polymerase IIIC (PolC)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

History / paused

ibezapolstat

DNA polymerase IIIC (PolC)

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ACXP PR & News

PR & News

ACXP SEC archive